PD-L1 targeted peptide demonstrates potent antitumor and immunomodulatory activity in cancer immunotherapy
Article in Frontiers in Immunology (April 2024)
The most recent citing publications are shown below. View all 16 publications that cite this research output on Dimensions.
An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer
Article in Non-Coding RNA (November 2023)
Immune Modulatory Long-Non-Coding RNA as a Potential Therapeutic Target in Cancer
Preprint in Preprints.org (July 2023)